Effects of Combined Treatment with Resveratrol and Indole-3-Carbinol

被引:6
|
作者
Trusov, N. V. [1 ]
Guseva, G. V. [1 ]
Aksenov, I. V. [1 ]
Avren'eva, L. I. [1 ]
Kravchenko, L. V. [1 ]
Tutelyan, V. A. [1 ]
机构
[1] Russian Acad Med Sci, Inst Nutr, Moscow 109801, Russia
关键词
resveratrol; indole-3-carbinol; xenobiotic metabolism enzymes; antioxidant state; NRF2; ANTIOXIDANT; ACTIVATION; EXPRESSION; TOXICITY; RECEPTOR; RNA;
D O I
10.1007/s10517-010-0910-7
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Male Wistar rats received a semisynthetic diet with resveratrol (100 mg/kg), indole-3-carbinol (20 mg/kg), or a mixture of these compounds in the same doses for 1 week. Activities of ethoxyresorufin dealkylase (EROD), methoxyresorufin dealkylase (MROD), pentoxyresorufin dealkylase (PROD), and 6 beta-testosterone hydroxylase (6 beta-TH) and the content of mRNA for CYP1A1, CYP1A2, and CYP3A1 were elevated in the liver of rats receiving indole-3-carbinol. These changes were accompanied by an increase in activity of phase II xenobiotic metabolism enzymes (quinone reductase, hemoxygenase-1, glutathione transferase, and UDP glucuronosyl transferase). Resveratrol did not modify activity of these enzymes. After combined treatment with the test compounds, resveratrol suppressed the indole-3-carbinol-induced increase in activities of EROD, MROD, PROD, and 6 beta-TH, and expression of the corresponding genes. Combined treatment was characterized by potentiation of the antioxidant effects of these compounds.
引用
收藏
页码:213 / 218
页数:6
相关论文
共 50 条
  • [31] A randomized phase II trial of indole-3-carbinol in the treatment of vulvar intraepithelial neoplasia
    Naik, R
    Nixon, S
    Lopes, A
    Godfrey, K
    Hatem, MH
    Monaghan, JM
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (02) : 786 - 790
  • [32] The natural chemopreventive compound indole-3-carbinol: State of the science
    Rogan, EG
    [J]. IN VIVO, 2006, 20 (02): : 221 - 228
  • [33] Indole-3-carbinol - A novel approach to breast cancer prevention
    Bradlow, HL
    Sepkovic, DW
    Telang, NT
    Osborne, MP
    [J]. CANCER PREVENTION: FROM THE LABORATORY TO THE CLINIC: IMPLICATIONS OF GENETIC, MOLECULAR, AND PREVENTIVE RESEARCH, 1995, 768 : 180 - 200
  • [34] Endocrine disruption by indole-3-carbinol and tamoxifen: Blockage of ovulation
    Gao, XN
    Petroff, BK
    Oluola, O
    Georg, G
    Terranova, SPF
    Rozman, KK
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2002, 183 (03) : 179 - 188
  • [35] Inhibition of MUC1 expression by indole-3-carbinol
    Lee, IJ
    Han, F
    Baek, J
    Hisatsune, A
    Kim, KC
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (06) : 810 - 816
  • [36] Indole-3-carbinol: Anticarcinogen or tumor promoter in brassica vegetables?
    Dashwood, RH
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 1998, 110 (1-2) : 1 - 5
  • [37] Inhibitory effects of Indole-3-carbinol on invasion and migration in human breast cancer cells
    Meng, QH
    Goldberg, ID
    Rosen, EM
    Fan, SJ
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2000, 63 (02) : 147 - 152
  • [38] Antiplatelet and antithrombotic activity of indole-3-carbinol in vitro and in vivo
    Park, Min-Kyu
    Rhee, Yun-Hee
    Lee, Hyo-Jung
    Lee, Eun-Ok
    Kim, Kwan-Hyun
    Park, Min-Jong
    Jeon, Byung-Hun
    Shim, Bum-Sang
    Jung, Chanf-Hyun
    Choi, Seung-Hoon
    Ahn, Kyoo-Seok
    Kim, Sung-Hoon
    [J]. PHYTOTHERAPY RESEARCH, 2008, 22 (01) : 58 - 64
  • [39] INDUCTION OF ESTRADIOL METABOLISM BY DIETARY INDOLE-3-CARBINOL IN HUMANS
    MICHNOVICZ, JJ
    BRADLOW, HL
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (11) : 947 - 949
  • [40] INVITRO METABOLISM OF THE DIETARY CHEMOPROTECTIVE AGENT, INDOLE-3-CARBINOL
    TABOR, MW
    SHERTZER, HG
    MYERS, BL
    [J]. FASEB JOURNAL, 1988, 2 (05): : A1136 - A1136